Get started
Author

Heather M. Heerssen

Observed names: Heather Heerssen, Heather M Heerssen, Heather Marie Heerssen, M. Heerssen, Heather
Observed institutions: Harvard University, University of California, San Francisco, Washington and Lee University, Washington University in St. Louis, Dana-Farber Cancer Institute, Kyowa Kirin (United States)
ORCID: 0009-0007-3088-2883
Observed ORCID: 0009-0007-3088-2883
OpenAlex ID: A5018448641
Neurotrophins use the Erk5 pathway to mediate a retrograde survival response
2001 · Fiona L. Watson, Heather M. Heerssen, et al. · Nature Neuroscience · 446
Rapid Nuclear Responses to Target-Derived Neurotrophins Require Retrograde Transport of Ligand–Receptor Complex
1999 · Fiona L. Watson, Heather M. Heerssen, et al. · Journal of Neuroscience · 273
PDF
Dynein motors transport activated Trks to promote survival of target-dependent neurons
2004 · Heather M Heerssen, Maria F Pazyra, et al. · Nature Neuroscience · 234
Location, location, location: a spatial view of neurotrophin signal transduction
2002 · Heather M Heerssen, Rosalind A Segal · Trends in Neurosciences · 137
Clathrin Dependence of Synaptic-Vesicle Formation at the Drosophila Neuromuscular Junction
2008 · Heather Heerssen, Richard D. Fetter, et al. · Current Biology · 135
PDF
A Retrograde Neuronal Survival Response: Target-Derived Neurotrophins Regulate MEF2D and bcl-w
2009 · Maria F. Pazyra-Murphy, Aymeric Hans, et al. · Journal of Neuroscience · 85
PDF
Stathmin is Required for Stability of the Drosophila Neuromuscular Junction
2011 · Ethan R. Graf, Heather M. Heerssen, et al. · Journal of Neuroscience · 62
PDF
Real-World Clinical and Healthcare Resource Burden Among Burosumab-Naïve Patients With Familial Hypophosphatemia
2024 · Erik A Imel, Zhiyi Li, et al. · Journal of the Endocrine Society · 5
PDF
Real-world characteristics & disease history of patients with X-linked hypophosphatemia before treatment with burosumab
2025 · Kathryn M. Dahir, Zhiyi Li, et al. · Archives of Osteoporosis · 3
PDF
Real-world effectiveness of burosumab across age groups: X-linked hypophosphatemia (XLH) Disease Monitoring Program
2026 · Leanne M Ward, Thomas O Carpenter, et al. · The Journal of Clinical Endocrinology & Metabolism · 2
Erratum: Neurotrophins use the Erk5 pathway to mediate a retrograde survival response
2002 · Fiona L. Watson, Heather M. Heerssen, et al. · Nature Neuroscience · 2
PDF
Supplementary Information
2026 · Li, Jerry, Ward, Leanne M., et al. · Figshare · 1
Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment
2026 · Anthony A Portale, Suzanne M Jan de Beur, et al. · JBMR Plus · 1
THU394 Disease Burden Of X-Linked Hypophosphatemia Focused On The United States And Canada: A Targeted Literature Review
2023 · Zhiyi Li, Omer Zaidi, et al. · Journal of the Endocrine Society · 1
SUN-757 Sustained Improvements in Patient-Reported Outcomes Across Age Groups in Burosumab-Treated X-linked Hypophosphatemia (XLH): Results From the XLH Disease Monitoring Program
2025 · Aliya Aziz Khan, Thomas O Carpenter, et al. · Journal of the Endocrine Society
PDF
Works count: 16
Citation count: 1,388
H-index: 7
I10-index: 7
Year
Topic
Type